Author
Listed:
- Chengzhang Li
(College of Life Science, Henan Normal University, Xinxiang 453007, China)
- Jiucheng Xu
(College of Life Science, Henan Normal University, Xinxiang 453007, China
Engineering Lab of Intelligence Business & Internet of Things, College of Computer and Information Engineering, Henan Normal University, Xinxiang 453007, China)
Abstract
Background: Hepatocellular carcinoma (HCC) is a major threat to public health. However, few effective therapeutic strategies exist. We aimed to identify potentially therapeutic target genes of HCC by analyzing three gene expression profiles. Methods: The gene expression profiles were analyzed with GEO2R, an interactive web tool for gene differential expression analysis, to identify common differentially expressed genes (DEGs). Functional enrichment analyses were then conducted followed by a protein-protein interaction (PPI) network construction with the common DEGs. The PPI network was employed to identify hub genes, and the expression level of the hub genes was validated via data mining the Oncomine database. Survival analysis was carried out to assess the prognosis of hub genes in HCC patients. Results: A total of 51 common up-regulated DEGs and 201 down-regulated DEGs were obtained after gene differential expression analysis of the profiles. Functional enrichment analyses indicated that these common DEGs are linked to a series of cancer events. We finally identified 10 hub genes, six of which ( OIP5 , ASPM , NUSAP1 , UBE2C , CCNA2 , and KIF20A ) are reported as novel HCC hub genes. Data mining the Oncomine database validated that the hub genes have a significant high level of expression in HCC samples compared normal samples ( t -test, p < 0.05). Survival analysis indicated that overexpression of the hub genes is associated with a significant reduction ( p < 0.05) in survival time in HCC patients. Conclusions: We identified six novel HCC hub genes that might be therapeutic targets for the development of drugs for some HCC patients.
Suggested Citation
Chengzhang Li & Jiucheng Xu, 2020.
"Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma,"
IJERPH, MDPI, vol. 17(3), pages 1-12, February.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:3:p:1053-:d:317696
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:3:p:1053-:d:317696. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.